Advertisement
Advertisement
Trending on Dermatology Times
1
Modern Psoriasis Treatment: From Topicals to IL-23 and IL-17 Biologics
2
Comparing Safety Profiles of Checkpoint Inhibitors in cSCC
3
Palmoplantar Psoriasis Data Show Zasocitinib Edge Over Apremilast
4
Oral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial
5